Buy, sell or hold after Lilly’s Alzheimer’s flop?
Analysts are all over the map on how investors should react to the Indianapolis-based drugmaker’s news that a promising drug failed to help patients.
John Russell
Articles
Failure of Lilly’s Alzheimer’s drug not a big surprise to analysts
Investors pummeled Eli Lilly and Co.’s stock Wednesday on the news that its experimental drug for Alzheimer’s disease failed to help patients, but a chorus of pharmaceutical analysts say they weren’t shocked by the setback.
Indiana utility watchdog Stippler set to retire
David Stippler, Indiana’s official advocate for utility customers, who often pushes back against utilities that want to raise rates, plans to retire Jan. 1 after 11 years in office.
Purdue keeping tons of lab gloves from landfills
What happens to a laboratory glove after a doctor, nurse or lab worker snaps it off and throws it in the bin? Usually, it goes to a landfill, but Purdue and partners are working to change that.
Hospital food alert: Why Methodist is upgrading its massive kitchen
Hospitals are under pressure to serve healthier fare. Patients, health groups and news organizations are turning up the fire.
Patients rush to surgery before insurance deductibles reset
For patients, the difference between getting an operation now or in January could amount to thousands of dollars out of pocket.
Addiction-treatment center Fairbanks names new CEO
Fairbanks, an Indianapolis not-for-profit that focuses on treating alcohol and drug addiction, has changed its leadership again, just a year after bringing in a new executive from Ohio.
Another small hospital to fly the IU Health flag
IU Health continues to pick up small hospitals around the state to help feed patients into its vast network.
Auditor says Eskenazi fired her for identifying improper billing
Colette D. Jackson claims in a lawsuit that Eskenazi retaliated against her after she discovered the hospital was improperly billing the federal government and Indiana for potentially hundreds of patients whose bills were already being paid by research grants.
Fired manager files discrimination suit against Eskenazi Health
A former manager at Eskenazi Health claims she was fired after complaining that her boss was pressuring her to hire more minorities.
IPL battery installation sparks tiff with MISO
A dispute has broken out over the financial terms under which IPL connects its new, $25 million, energy-storage system to the grid.
Carmel phone retailer Round Room acquires 357-store chain
Round Room LLC, which operates hundreds of stores under the name TCC (formerly The Cellular Connection), said the deal to acquire Wireless Zone of Rocky Hill, Connecticut, will expand its footprint to 1,160 stores in 41 states.
Pharmacy board member fined for conflict of interest
The vice president of the Indiana Board of Pharmacy has agreed to pay a fine for participating in several votes involving a pharmacy he was buying.
Writing about my own cancer
Writing about medical research is one thing. Learning about your own cancer—then trying to write about it—is another.
Higher medical claims contribute to Anthem earnings miss
The health insurance giant saw its largest expense, medical claims paid, climb more than 9 percent in the quarter, to $16.92 billion.
UPDATE: Johnson Memorial plans $42M overhaul of Franklin campus
In the largest project in its history, Johnson Memorial plans to demolish its old hospital building and construct two new health care facilities.
Rules mandate some firms cover transgender services
Starting Jan. 1, any health care organization that takes federal money for health purposes can’t refuse to provide transgender services.
Indy-based NICO works for acceptance of less invasive brain surgery tools
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Lilly pledges $90 million to improve global drug access
Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
Mainstreet accused of not paying nearly $2M in fees to adviser
A Chicago investment broker says the Carmel-based developer of transitional care properties is refusing to pay up for lining up a major investor in several projects.